Brown Gibbons Lang & Company (BGL) is pleased to announce its representation of Bioquell PLC (LSE: BQE) in its sale to Ecolab Inc. (NYSE: ECL). BGL’s Healthcare & Life Sciences team served as the exclusive financial advisor to Bioquell in the transaction.
Ecolab acquired 100 percent of the outstanding shares of Bioquell with total consideration payable to shareholders following anticipated option exercises of approximately £139 million ($178 million), subject to determination of the final share count.
Bioquell offers a unique opportunity to broaden Ecolab’s portfolio of products, services, and solutions. Bioquell’s expertise in bio-decontamination and deep-cleaning utilizing vaporized hydrogen peroxide technologies complements Ecolab’s daily cleaning and disinfection offerings for cleanrooms and other high-grade environments.
Headquartered in Andover, U.K., Bioquell is a leading provider of hydrogen peroxide vapor bio-decontamination systems and services. Bioquell’s innovative bio-decontamination and isolator technologies and services help ensure residue-free surface decontamination in cleanrooms and research and development labs at biotech start-ups, pharmaceutical manufacturers and Fortune 500 companies, and inpatient rooms at hospitals in more than 50 countries. For more information, please visit www.bioquell.com.